Tower Research Capital (TRC)’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-137
| Closed | -$14.6K | – | 5644 |
|
|
2025
Q3 | $14.6K | Buy |
137
+65
| +90% | +$6.79K | ﹤0.01% | 3589 |
|
|
2025
Q2 | $6.81K | Sell |
72
-66
| -48% | -$4.89K | ﹤0.01% | 4090 |
|
|
2025
Q1 | $8.76K | Sell |
138
-770
| -85% | -$46.1K | ﹤0.01% | 3855 |
|
|
2024
Q4 | $42.2K | Sell |
908
-52
| -5% | -$1.95K | ﹤0.01% | 2663 |
|
|
2024
Q3 | $27.6K | Sell |
960
-206
| -18% | -$5.07K | ﹤0.01% | 3060 |
|
|
2024
Q2 | $16.9K | Buy |
1,166
+466
| +67% | +$6.8K | ﹤0.01% | 3851 |
|
|
2024
Q1 | $11.3K | Sell |
700
-3,795
| -84% | -$65.6K | ﹤0.01% | 3585 |
|
|
2023
Q4 | $89.4K | Buy |
4,495
+4,067
| +950% | +$60K | ﹤0.01% | 2730 |
|
|
2023
Q3 | $6.98K | Sell |
428
-2,710
| -86% | -$52.2K | ﹤0.01% | 4528 |
|
|
2023
Q2 | $66.3K | Sell |
3,138
-1,396
| -31% | -$29.8K | ﹤0.01% | 2349 |
|
|
2023
Q1 | $91K | Buy |
4,534
+3,803
| +520% | +$82.1K | ﹤0.01% | 1961 |
|
|
2022
Q4 | $19K | Buy |
731
+178
| +32% | +$2.37K | ﹤0.01% | 3192 |
|
|
2022
Q3 | $6K | Sell |
553
-1,573
| -74% | -$13.3K | ﹤0.01% | 5066 |
|
|
2022
Q2 | $8K | Buy |
2,126
+1,095
| +106% | +$4.68K | ﹤0.01% | 4716 |
|
|
2022
Q1 | $5K | Buy |
1,031
+698
| +210% | +$4.06K | ﹤0.01% | 5116 |
|
|
2021
Q4 | $2K | Sell |
333
-1,444
| -81% | -$7.38K | ﹤0.01% | 5678 |
|
|
2021
Q3 | $10K | Buy |
1,777
+412
| +30% | +$2.4K | ﹤0.01% | 4346 |
|
|
2021
Q2 | $9K | Buy |
+1,365
| New | +$9.46K | ﹤0.01% | 4452 |
|
|
2020
Q3 | – | Sell |
-200
| Closed | -$1K | – | 5127 |
|
|
2020
Q2 | $1K | Buy |
+200
| New | +$926 | ﹤0.01% | 4649 |
|
|
2019
Q3 | – | Sell |
-262
| Closed | -$1K | – | 4542 |
|
|
2019
Q2 | $1K | Sell |
262
-104
| -28% | -$634 | ﹤0.01% | 3496 |
|
|
2019
Q1 | $2K | Sell |
366
-76
| -17% | -$495 | ﹤0.01% | 3466 |
|
|
2018
Q4 | $4K | Buy |
442
+187
| +73% | +$2.12K | ﹤0.01% | 3075 |
|
|
2018
Q3 | $3K | Hold |
255
| – | – | ﹤0.01% | 3345 |
|
|
2018
Q2 | $3K | Sell |
255
-215
| -46% | -$3.62K | ﹤0.01% | 3260 |
|
|
2018
Q1 | $9K | Buy |
+470
| New | +$6.79K | ﹤0.01% | 2510 |
|
|
2017
Q4 | – | Sell |
-199
| Closed | -$3K | – | 4067 |
|
|
2017
Q3 | $3K | Buy |
+199
| New | +$2.63K | ﹤0.01% | 3497 |
|
Other funds holding VRNA
Tower Research Capital (TRC)'s VRNA Position: Q4 2025 in Review
Tower Research Capital (TRC) sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 137 shares — an estimated $14.6K sold.
Tower Research Capital (TRC) first reported a position in VRNA in Q3 2017 and held it in 26 quarters. The position peaked at $91K in Q1 2023. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- Tower Research Capital (TRC) reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 137 Verona Pharma shares in Q4 2025, an estimated $14.6K.
- Tower Research Capital (TRC) first reported a position in Verona Pharma in Q3 2017 and held it in 26 quarters.
- Tower Research Capital (TRC)'s Verona Pharma position peaked at $91K in Q1 2023.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.